Skip to main content
. 2021 Aug 17;8:663670. doi: 10.3389/fmed.2021.663670

Table 3.

Comparison between the initial on admission laboratory and radiology finding and post-COVID-19 recovery (following negative PCR) 4-week follow-up.

Parameters Initial findings during admission Post-COVID-19 4-week follow-up t-test (95% CI)
Chest X-ray consolidation 13.36 ± 11.35 0 p < 0.0001****
Hemoglobin 13.28 ± 1.55 13.35 ± 1.75 p = 0.824
ESR 31.42 ± 19.41 18.89 ± 9.83 p < 0.0001****
WBC total count 7,162 ± 3,005 1,035 ± 1,999 p = 0.036**
RBC 4.94 ± 6.78 5.16 ± 0.70 p = 0.0837
Platelet 230,859 ± 66,213 232,016 ± 75,655 p = 0.93
Neutrophil 65.97 ± 12.71 62.75 ± 8.21 p = 0.0741
Lymphocyte 28.42 ± 12.52 36.24 ± 9.56 p < 0.0001****
Monocyte 3.78 ± 2.34 3.33 ± 2.32 p = 0.289
Eosinophil 1.75 ± 1.24 2.08 ± 1.16 p = 0.57
Basophil 0.067 ± 0.25 0.080 ± 0.27 p = 0.77
CRP 29.86 ± 23.65 5.3 ± 9.07 p < 0.0001****
SGPT 62.71 ± 45.18 49.13 ± 23.35 p = 0.0385*
Serum ferritin 543.3 ± 460.6 162 ± 105.2 p < 0.0001****
Prothrombin time 11.67 ± 1.92 12.59 ± 1.74 p = 0.0063**
D-dimer 1.05 ± 1.24 0.08 ± 0.18 p < 0.0001****
Serum creatinine 1.028 ± 0.27 0.85 ± 0.26 p = 0.0003***

Data are presented as mean ± SD. For the reference values, please see Table 7.

COVID-19, coronavirus disease 2019; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; RBC, red blood cell; SGPT, serum glutamic pyruvic transaminase; WBC, white blood cell. Level of significance of the p-value *, **, ***, ****.